I am a Consultant Pulmonologist and Professor of Practice in Cardiopulmonary Medicine #PulmonaryEmbolism, #PulmonaryHypertension and exercise physiology
London, UK
Joined November 2014
- Tweets3.8K
- Following403
- Followers2K
- Likes2K
Great job. Well done.
Professor Stefano Margaritora, who operated on Pope Leo XIV on October 13, speaks to Vatican News about the Holy Father's health.
He said the Pope "truly put his heart" into his treatment, and could be "fully recovered" in about ten days.
There are "no clinical reasons" why his planned trip to South America in November should not take place, Prof. Margaritora told Andrea Tornielli, Editorial Director of the Dicastery for Communication.
Luke Howard retweeted
Pope Leo XIV celebrated Mass at noon on Friday in the room set up on the 10th floor of Gemelli Hospital, according to the Holy See Press Office.
Several members of Gemelli's medical and nursing staff attended the Mass, along with members of the Vatican City State Gendarmerie Corps.
"In his homily, the Pope thanked all the staff—doctors, nurses, and orderlies—for the work they do every day caring for patients in their frailty, and especially for what they have done and continue to do for him," read the statement.
Luke Howard retweeted
New #HFA_ESC Journal Club!
Could #sotatercept offer a new therapeutic approach for pulmonary hypertension associated with #HFpEF? 🫀🫁
Join our next #HFAJournalClub as we discuss:
- Understanding CpcPH-HFpEF and its haemodynamic characteristics
- Key findings & limitations of the CADENCE trial
- Sotatercept & emerging approaches targeting pulmonary vascular remodelling
- Implications for future research & clinical management
📍Faculty: @mardigomberg @HelpMyBreathing @corneliacrm #ThomasGorter
📍19 Oct 2026 | 18:00 CET
📍Register now: esc365.escardio.org/event/27…
#HFAyoung @escardio
@h_arfsten @GTersalvi @jozinetm
Luke Howard retweeted
This is incredible. 80,000 young French Catholics sing the Salve Regina in Latin with Pope Leo XIV at a Prayer Vigil in the Stade de France.
Luke Howard retweeted
Incremental, symptom-limited CPET is safe in patients with suspected or confirmed pulmonary hypertension. In over 3800 tests, no deaths or syncopal events occurred, with an adverse event rate of only 0.05%, supporting wider use under proper supervision. bit.ly/4qdZf6x
Been off X for a while but this irked me. Luke Howard (the OG) who named the clouds would not have approved. Clouds are things of beauty... @CloudAppSoc
BBC News - Covid cases rising with new variants Nimbus and Stratus
bbc.com/news/articles/c3rv3y…
If you're at #ERSCongress in Amsterdam next week, join us for a symposium, Charting the Course for Personalised Pulmonary Arterial Hypertension Care on Tuesday, 30th September at 12.45pm CET.
Registration URL: medscape.org/symposium/pulmo…
So glad I stopped paying money to this shower years ago
Attendees at the #RDconf last Saturday voted on an emergency motion to show their opposition to the Supreme Court ruling on the definition of a woman.
Read the motion below 👇
BMA-wide policy is set at the Annual Representative Meeting (ARM) in June 2025.
ALT Emergency motion on the Supreme Court ruling defining the term 'woman' from RDC conference 2025
Luke Howard retweeted
🚨 Only 3 Days Left!
Time’s running out to get Circular Ring 2 at the best launch price ever.
This is your last chance to join the future of health tracking.
👉 Don’t wait — back now on Kickstarter!
🔗 bit.ly/circular_Kickstarter
Just 2 days left of this @circularing kickstarter. We have nearly 10, 000 backers. The response has been insane
kickstarter.com/projects/cir…
Prof Millicent Stone presenting the latest @iOWNAwHealth feature of Pathways. Integration of information and diagnostics leading to personalised content.
Am so happy to see this work out. 15 years of data collection from setting up the exercise service from scratch.
Thanks to all those who have worked on this and to Andrea for pushing the boulder up the steepest part of the hill
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more